Variant report
Variant | esv3528035 |
---|---|
Chromosome Location | chr13:96017752-96025002 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr13:96010392..96012474-chr13:96022109..96025076,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs9584296 | chr13:96019415-96019416 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs569541475 | chr13:96019436-96019437 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs538196800 | chr13:96019487-96019488 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs555197971 | chr13:96019533-96019534 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs546843790 | chr13:96019546-96019547 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs533856471 | chr13:96019594-96019595 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs553921814 | chr13:96019693-96019694 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs146295179 | chr13:96019706-96019707 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs576881240 | chr13:96019716-96019717 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs545787926 | chr13:96019717-96019718 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs562603613 | chr13:96019738-96019739 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs139781300 | chr13:96019761-96019762 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs532339623 | chr13:96019773-96019774 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs3848073 | chr13:96019789-96019790 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs144505222 | chr13:96019797-96019798 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs151090778 | chr13:96019801-96019802 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs546658123 | chr13:96019813-96019814 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs374101987 | chr13:96019819-96019820 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs557029605 | chr13:96019835-96019836 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs560214751 | chr13:96019837-96019838 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs139840440 | chr13:96019838-96019839 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs552532721 | chr13:96019839-96019840 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs190372547 | chr13:96019882-96019883 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs368288351 | chr13:96019899-96019900 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs538508676 | chr13:96019902-96019903 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs372071152 | chr13:96019941-96019942 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs548933502 | chr13:96019949-96019950 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs375183506 | chr13:96019953-96019954 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs192635173 | chr13:96019955-96019956 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs76914380 | chr13:96019956-96019957 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs149909609 | chr13:96019986-96019987 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs375747950 | chr13:96020064-96020065 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs111636468 | chr13:96020068-96020069 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs113788673 | chr13:96020093-96020094 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs75622584 | chr13:96020127-96020128 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs369089428 | chr13:96020146-96020147 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs75881671 | chr13:96020156-96020157 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs111953074 | chr13:96020231-96020232 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs561667457 | chr13:96020235-96020236 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs12868046 | chr13:96020245-96020246 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs12868576 | chr13:96020246-96020247 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs145806365 | chr13:96020250-96020251 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs184253763 | chr13:96020257-96020258 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs111669152 | chr13:96020263-96020264 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs147768510 | chr13:96020276-96020277 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs112190273 | chr13:96020281-96020282 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs369544802 | chr13:96020285-96020286 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs9561859 | chr13:96020342-96020343 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs549108493 | chr13:96020361-96020362 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs552416698 | chr13:96020398-96020399 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Breast cancer | 17133270 | CNVD |
Prostate cancer | 18632612 | CNVD |
Melanoma | 18172304 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Gastric cancer | 17908304 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Omodysplasia | 19481194 | CNVD |
Breast cancer | 22032731 | CNVD |
Rhabdomyosarcoma | 17210683 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Wilms tumour | 21544195 | CNVD |
Developmental delay | 21147756 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 17603634 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Thyroid cancer | 19087340 | CNVD |
abortions and stillbirths | 19751515 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Acute myeloid leukemia | 19651601 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20467480 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Intellectual disability | 22102821 | CNVD |
Burkitt''s lymphoma | 20823134 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:96019400-96019800 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
2 | chr13:96019600-96020200 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
3 | chr13:96019600-96020200 | Enhancers | NHDF-Ad | bronchial |
4 | chr13:96019800-96024800 | Weak transcription | Fetal Adrenal Gland | Adrenal Gland |
5 | chr13:96024000-96032600 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
6 | chr13:96024800-96025200 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |